Hi! Welcome Back and Stay Tune! A cancer drug that AbbVie acquired in a $10 billion deal is looking more and more like a failure - Mukah Pages : Media Marketing Make Easy With 24/7 Auto-Post System. Find Out How It Was Done!

A cancer drug that AbbVie acquired in a $10 billion deal is looking more and more like a failure

Mimi Sabreena 4:14:00 PM Editor Choice

AbbVie revealed on Wednesday that it had halted patient enrollment in a late-stage clinical trial for a small-cell lung cancer drug after poor patient outcomes.

AbbVie just stopped enrolling patients in a late-stage trial of a high-profile lung cancer drug after patients had shorter survival results on the drug.

✍ Source Link : ☕ Business Insider Malaysia

Source :

(✿◠‿◠)✌ Enjoy reading and not forget to👍 Like & 💕 Share!

No comments

Comments are welcome and encouraged on this site. Comments deemed to be spam or solely promotional will be deleted. Including link to relevant content is permitted, but comments should be relevant to the post topic.

Comments including profanity and containing language that could deemed offensive will also deleted. Please respectful toward other contributors. Thank you.